--- title: "Stifel Nicolaus Remains a Buy on Cooper Co (COO)" type: "News" locale: "en" url: "https://longbridge.com/en/news/289597671.md" description: "Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Cooper Co (COO) with an $85 price target. This follows a Buy from Needham's David Saxon, while J.P. Morgan held a Hold rating on the same day. Block specializes in Healthcare stocks and has a 49.5% success rate." datetime: "2026-06-12T12:27:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289597671.md) - [en](https://longbridge.com/en/news/289597671.md) - [zh-HK](https://longbridge.com/zh-HK/news/289597671.md) --- # Stifel Nicolaus Remains a Buy on Cooper Co (COO) Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Cooper Co today and set a price target of $85.00. ### Introducing TipRanks MCP for Agents - Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. - Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. Block covers the Healthcare sector, focusing on stocks such as Align Tech, Dexcom, and Nyxoah. According to TipRanks, Block has an average return of 4.6% and a 49.50% success rate on recommended stocks. In addition to Stifel Nicolaus, Cooper Co also received a Buy from Needham’s David Saxon in a report issued on June 5. However, on the same day, J.P. Morgan maintained a Hold rating on Cooper Co (NASDAQ: COO). ### Related Stocks - [COO.US](https://longbridge.com/en/quote/COO.US.md) ## Related News & Research - [COOPER COMPANIES, INC. 2Q 2026: Revenue $1.08B, Net income ($77.9M), EPS ($0.4) — 10-Q Summary](https://longbridge.com/en/news/288904887.md) - [Cooper Companies Q2 revenue, profit beat estimates on product launches, strong demand](https://longbridge.com/en/news/288769821.md) - [H.C. Wainwright Sticks to Its Buy Rating for Shattuck Labs (STTK)](https://longbridge.com/en/news/289068921.md) - [Roth MKM Reaffirms Their Buy Rating on CervoMed (CRVO)](https://longbridge.com/en/news/289519604.md) - [TD Cowen Sticks to Their Buy Rating for Bio-Techne (TECH)](https://longbridge.com/en/news/289444397.md)